PDX Portal

Model Details

Patient Information for Model: TCCC-OS45

Model Contact

Model: TCCC-OS45
Model Contact: Nino Rainusso
Institution: TCH Sarcoma PDX Program
Email: ncrainuss@texaschildrens.org

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations

Pathology Information at Collection

Model Information for Model: TCCC-OS45

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

There are no omics data for this model.

Histology Information for Model: TCCC-OS45

There are no histology images for this model.

Metastasis Information for Model: TCCC-OS45

Patient

PDX

Bone

Lung

Patient Treatment Information for Model: TCCC-OS45

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response	Pathologic Response	Reason Stopped
10	Methotrexate, Doxorubicin, Cisplatin	Neoadjuvant	15.66	15.83	62 days	Partial response	Good response (>90% tumor necrosis)	Surgical resection (local control)
20	Methotrexate, Doxorubicin, Cisplatin	Adjuvant	15.91	16.25	124 days	No evidence of disease		End of therapy
30	Ifosfamide /Etoposide	Adjuvant	20.25	20.66	150 days	No evidence of disease		End of therapy